Amgen concludes $27.8bn acquisition of Horizon Therapeutics
The deal has secured clearance from the US Federal Trade Commission which prohibits Amgen from using any anti-competitive…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Oct 23
The deal has secured clearance from the US Federal Trade Commission which prohibits Amgen from using any anti-competitive…
09 Oct 23
The FDA has cleared Cosentyx as the first IV formulation interleukin-17A antagonist for adults with psoriatic arthritis, ankylosing…
09 Oct 23
TOFIDENCE is the first monoclonal antibody drug researched, developed, and manufactured by a Chinese pharmaceutical company to receive…
09 Oct 23
When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and…
06 Oct 23
The deal includes Mitokinin's lead asset, a selective PINK1 activator, which is designed to mitigate mitochondrial dysfunction factor…
05 Oct 23
Risvodetinib is a chronically administered oral drug candidate that targets the underlying biological mechanism of Parkinson’s disease with…
05 Oct 23
The program is designed to help patients access treatment, providing prescription fulfillment services, insurance benefits investigation, educational support,…
04 Oct 23
The United Nations’ health agency will consider the SAGE’s recommendation and revise its position paper on dengue vaccines…
04 Oct 23
The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization…
03 Oct 23
The drugmaker has received offer for its OTC business, and has agreed to divest its women's healthcare business,…